Understanding the correct approach helps maintain therapeutic effectiveness whilst minimising gastrointestinal side effects
It has split opinion and caused shockwaves through a once united, international lipoedema community, who have divided into two new factions: the International Lipedema Association (ILA) formed in 2022, who advocate the contents of the 2020 document, and the World Lipedema Alliance (WLA), formed in 2023, who do not
Of note, the percentage of patients treated with SGLT2 inhibitors is very low in our cohorts, but this finding is likely due to prescription limitations for the SGLT2i/GLP1-RA combination according to the Italian drug agency
There's a huge demand for the drugs, but also employers realize that when used appropriately they can work and it can be a really good talent attraction and talent retention tool." The findings of the Gallup index are based on a web survey of 5,065 U.S